ftInvstr
SIGACHI · Healthcare ₹34.84 +7.27% Mkt Cap ₹1332 Cr

SIGACHI

Healthcare Drug Manufacturers - Specialty & Generic
₹34.84
+7.27% today · 30d +35.25%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SIGACHI. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹122 Cr
-4.92% YoY
NET PROFIT
₹8 Cr
-52.71% YoY
OPM
14.41%
-9.17pp YoY
EPS
₹0.2
PE 51.36
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SIGACHI51.3616.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
57
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth MUTED 31
Profitability DECENT 68
Technicals NEUTRAL 68
Risk LOW 80
Key Stats
TTM PE
51.36
P/B
2.54
52W HIGH
₹46.73
OFF HIGH
-25.44%
DIV YIELD
0.29%
MKT CAP
₹1332 Cr
◉ Active Signals
MACDBullish0.1635
RSI(14)Bearish71.98
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SIGACHI and at what entry.

Sign up freeSign in